Login

Financial Snapshot

Revenue
TTM
$27.48M
Gross Margin
TTM
56.22%
Net Income
TTM
-$21.08M
Current Assets
2025 Q2
Current Liabilities
2025 Q2
Current Ratio
2025 Q2
283.8%
Total Assets
2025 Q2
Total Liabilities
2025 Q2
Book Value
2025 Q2
$43.40M
Cash
2025 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$12.74M

Stock Price

Loading...
Market Cap: $36.64 Million

About ENZO BIOCHEM INC

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company is headquartered in Farmingdale, New York and currently employs 125 full-time employees. The firm's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including portfolio of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. It's products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry.

Industry: Biological Products, (No Diagnostic Substances) Peers: AKUMIN INC. Biodesix Inc Bimergen Energy Corp Cryo-Cell International Inc CVS Health Corp InfuSystem Holdings Inc Talkspace Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support